Align shares closed down 0.7% post-earnings, indicating a fairly muted investor reaction despite management highlighting year-over-year growth in key segments. Solid Clear Aligner volumes and international growth were balanced by a sequential decline in Systems & Services and overall margin commentary that did not notably exceed expectations.

• Q1 revenue was $1.04 billion, up 6.2% year-over-year, primarily driven by Clear Aligner volumes and higher ASPs.
• Clear Aligner shipments reached a quarterly record of 686,000 cases, up 6.7% year-over-year, and Clear Aligner revenue grew 7.4% to $856 million.
• All major regions saw double-digit Clear Aligner volume growth except North America, which remained stable.
• Systems and Services revenue totaled $184 million, up 1% year-over-year but declined sequentially, reflecting anticipated capital equipment seasonality and a continued mix shift toward lower-priced scanner offerings.
• Doctor utilization and the number of submitting doctors both increased globally, though topline and segment trends appeared largely in line with expectations, as reflected by the modest market move.